Table 3 Prevalence of autoantibodies in anti-Rib-P-positive samples (n = 51)
| Â | Positive + borderline, number (percentage) | Positive, number (percentage) |
|---|---|---|
Mikrogen ENA line assaya | ||
   Histone | 38 (74.5) | 18 (35.3) |
   dsDNA | 34 (66.7) | 14 (27.5) |
   SmB | 23 (45.1) | 13 (25.5) |
   Ro52 | 22 (43.1) | 17 (33.3) |
   SmD | 21 (41.2) | 6 (11.8) |
   SS-A/Ro60 | 21 (41.2) | 13 (25.5) |
   Rib-P | 19 (37.3) | 13 (25.5) |
   RNPA | 11 (21.6) | 8 (15.7) |
   RNPC | 8 (15.7) | 5 (9.8) |
   SS-B/La | 7 (13.7) | 7 (13.7) |
   PCNA | 6 (11.8) | 3 (5.9) |
   RNP68 | 4 (7.8) | 3 (5.9) |
   CENPB | 3 (5.9) | 2 (3.9) |
   Topoisomerase-I | 2 (3.9) | 1 (2.0) |
   Jo-1 | 1 (2.0) | 1 (2.0) |
ELISA | ||
   Rib-P | 36 (70.6) | 27 (52.9) |
ALBIA | ||
   Rib-P | 51 (100.0) | 27 (52.9) |
   Chromatin | 27 (52.9) | 22 (43.1) |
   Ro52 | 13 (25.5) | 12 (23.5) |
   SS-A/Ro60 | 11 (21.6) | 8 (15.7) |
   RNP | 8 (15.7) | 2 (3.9) |
   Topoisomerase I | 8 (15.7) | 4 (7.8) |
   Sm | 8 (15.7) | 5 (9.8) |
   Jo-1 | 1 (2.0) | 0 (0.0) |
   SS-B/La | 1 (2.0) | 1 (2.0) |